Clinical trial
Prevention of Severe Hypoglycemia in Type 1 Diabetes
NCT00360984 · Newcastle University, Other · Completed
Key facts
| NCT number | NCT00360984 |
|---|---|
| Title | Prevention of Severe Hypoglycemia in Type 1 Diabetes |
| Official title | Can Hypoglycaemia Awareness Be Restored in Individuals With Type 1 Diabetes and Severe Hypoglycaemia Employing Optimised Subcutaneous Insulin Regime or Continuous Subcutaneous Insulin Infusion Pump |
| Lead sponsor | Newcastle University, Other |
| Collaborators | Newcastle-upon-Tyne Hospitals NHS Trust Newcastle Primary Care Trust Sanofi Industry Medtronic |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Device, Drug |
| Interventions | insulin glargine, continuous subcutaneous insulin infusion |
| Enrollment | 21 |
| Start date | May 1, 2003 |
| Completion | Sep 1, 2004 |
| First posted | Aug 7, 2006 |
| Last update posted | Aug 7, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: